Research

Somatic retrotransposition in human cancer revealed by whole-genome and exome sequencing

    • 1Harvard-MIT Division of Health Sciences & Technology, Cambridge, Massachusetts 02139, USA;
    • 2Broad Institute of MIT and Harvard, Cambridge, Masachusetts 02142, USA;
    • 3Massachusetts General Hospital, Boston, Massachusetts 02114, USA;
    • 4Center for Cancer Genome Discovery and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA;
    • 5Department of Pathology, Brigham & Women’s Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA
Published May 13, 2014. Vol 24 Issue 7, pp. 1053-1063. https://doi.org/10.1101/gr.163659.113
Download PDF Please log-in to or register for your personal account in order to access PDF Cite Article Permissions Share
cover of Genome Research Vol 36 Issue 4
Current Issue:

Abstract

Retrotransposons constitute a major source of genetic variation, and somatic retrotransposon insertions have been reported in cancer. Here, we applied TranspoSeq, a computational framework that identifies retrotransposon insertions from sequencing data, to whole genomes from 200 tumor/normal pairs across 11 tumor types as part of The Cancer Genome Atlas (TCGA) Pan-Cancer Project. In addition to novel germline polymorphisms, we find 810 somatic retrotransposon insertions primarily in lung squamous, head and neck, colorectal, and endometrial carcinomas. Many somatic retrotransposon insertions occur in known cancer genes. We find that high somatic retrotransposition rates in tumors are associated with high rates of genomic rearrangement and somatic mutation. Finally, we developed TranspoSeq-Exome to interrogate an additional 767 tumor samples with hybrid-capture exome data and discovered 35 novel somatic retrotransposon insertions into exonic regions, including an insertion into an exon of the PTEN tumor suppressor gene. The results of this large-scale, comprehensive analysis of retrotransposon movement across tumor types suggest that somatic retrotransposon insertions may represent an important class of structural variation in cancer.

Loading
Loading
Back to top